Stay updated on BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew site revision tag added: Revision: v3.4.2, and the prior notice about funding/operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding notice about potential updates or responses and updated the page to Revision: v3.4.1 (replacing v3.4.0). These are administrative updates that do not alter the study details presented on the page.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now shows a glossary and new metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous version displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4, representing a minor page update with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section updated with expanded list of trial sites across multiple countries and regions, and the revision changed from v3.3.2 to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedVersion metadata updated from v3.2.0 to v3.3.2; this is a minor revision that does not affect study content, eligibility criteria, or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.